Page last updated: 2024-11-05

thalidomide and Bronchiolitis Obliterans

thalidomide has been researched along with Bronchiolitis Obliterans in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Bronchiolitis Obliterans: Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forsyth, CJ1
Cremer, PD1
Torzillo, P1
Iland, HJ1
Young, GA1
Heaton, DC1

Other Studies

2 other studies available for thalidomide and Bronchiolitis Obliterans

ArticleYear
Thalidomide responsive chronic pulmonary GVHD.
    Bone marrow transplantation, 1996, Volume: 17, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Bronchiolitis Obliterans; Cyclosporine;

1996
Failure of thalidomide to control bronchiolitis obliterans post bone marrow transplant.
    Bone marrow transplantation, 1989, Volume: 4, Issue:5

    Topics: Adult; Bone Marrow Transplantation; Bronchiolitis Obliterans; Graft vs Host Disease; Humans; Leukemi

1989